The Safety and Efficacy Evaluation of Hair Products Containing Probiotics
- Conditions
- Skin Problems
- Interventions
- Combination Product: Placebo groupCombination Product: Test group Probiotic Shampoo
- Registration Number
- NCT04566549
- Lead Sponsor
- GenMont Biotech Incorporation
- Brief Summary
Previous studies on skin health with Lactic acid bacteria (LAB) have been published for many years, including prevention of skin diseases and improvement of skin conditions. In this clinical study, the investigators researched the benefit effects of heat-killed Lactobacillus paracasei shampoo on scalp and hair healthcare.
- Detailed Description
To evaluate the safety and efficacy of hair products containing probiotics
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- Healthy volunteers between the ages of 20-70.
- Subjects are undergoing medical therapy for scalp, hair diseases or diabetes mellitus.
- Subjects with cosmetics allergy.
- Subjects had accepted the scalp surgery such as Follicular Unit Transpalnt, Follicular Unit Extraction in the past half year.
- Subjects with pregnancy or breast-feeding.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo group Placebo group Shampoo base without probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance. Test group Test group Probiotic Shampoo Shampoo base with probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance、Heat-killed Lactobacillus paracasei powders (5x10\^8 cells/ g-shampoo).
- Primary Outcome Measures
Name Time Method Skin Microbiota Baseline, 4 weeks and 8 weeks The changes of scalp microbiota will be evaluated by NGS or qPCR analysis at baseline and different timepoint post-intervention.
- Secondary Outcome Measures
Name Time Method The scalp flakes (dandruff) Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks The scalp flakes will be evaluated by D-SQAME ® DANDRUFF TESTER at baseline and different timepoint post-intervention.
The sebum on scalp Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks The scalp sebum will be measured by Sebumeter SM815 (C+K, Germany) at baseline and different timepoint post-intervention.
Adverse Event Baseline and 28 weeks Any adverse event, such as erythema,rash, itching and so on will be recorded during the intervention.
The hair density (hairs/scalp area) Baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks The hair number in a constant scalp area will be measured by Aramo TSII skin/hair diagnosis (Aramhuvis Co., Ltd. Korea) at baseline and different timepoint post-intervention.
Single application closed patch epicutaneous test under occlusion 1 hour, 24 hours and 48 hour Probiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.
Repeated application closed patch epicutaneous test under occlusion Day 1, 2, 3, 4 and 5 The irritation potential of probiotics on skin will be evaluated by Human Patch test.
The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.
Trial Locations
- Locations (1)
Chia Nan University of Pharmacy and Science
🇨🇳Tainan, Taiwan